Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause Second primary malignancy? 21 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Second primary malignancy have been filed in association with DOCETAXEL\DOCETAXEL ANHYDROUS. This represents 0.6% of all adverse event reports for DOCETAXEL\DOCETAXEL ANHYDROUS.
21
Reports of Second primary malignancy with DOCETAXEL\DOCETAXEL ANHYDROUS
0.6%
of all DOCETAXEL\DOCETAXEL ANHYDROUS reports
0
Deaths
8
Hospitalizations
How Dangerous Is Second primary malignancy From DOCETAXEL\DOCETAXEL ANHYDROUS?
Of the 21 reports, 8 (38.1%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOCETAXEL\DOCETAXEL ANHYDROUS. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause?
Diarrhoea (409)
Myelosuppression (404)
Disease progression (289)
Off label use (281)
Nausea (279)
Neutropenia (250)
Fatigue (236)
Pyrexia (221)
Vomiting (216)
Asthenia (190)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which DOCETAXEL\DOCETAXEL ANHYDROUS Alternatives Have Lower Second primary malignancy Risk?
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCOSANOL
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE